<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Cent Sci</journal-id><journal-id journal-id-type="iso-abbrev">ACS Cent Sci</journal-id><journal-id journal-id-type="publisher-id">oc</journal-id><journal-id journal-id-type="coden">acscii</journal-id><journal-title-group><journal-title>ACS Central Science</journal-title></journal-title-group><issn pub-type="ppub">2374-7943</issn><issn pub-type="epub">2374-7951</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7048371</article-id><article-id pub-id-type="doi">10.1021/acscentsci.9b01071</article-id><article-categories><subj-group><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Mesoscale All-Atom Influenza Virus Simulations Suggest New Substrate
Binding Mechanism</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Durrant</surname><given-names>Jacob D.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="notes2" ref-type="notes">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Kochanek</surname><given-names>Sarah E.</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="notes2" ref-type="notes">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Casalino</surname><given-names>Lorenzo</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="notes2" ref-type="notes">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Ieong</surname><given-names>Pek U.</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Dommer</surname><given-names>Abigail C.</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath6"><name><surname>Amaro</surname><given-names>Rommie E.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department of Biological
Sciences, <institution>University of Pittsburgh</institution>, Pittsburgh, Pennsylvania 15260, <country>United States</country></aff><aff id="aff2"><label>&#x02021;</label>Department of Chemistry and Biochemistry, <institution>University of California, San Diego</institution>, La Jolla, California 92093-0340, <country>United States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>E-mail: <email>ramaro@ucsd.edu</email>.</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>02</month><year>2020</year></pub-date><pub-date pub-type="ppub"><day>26</day><month>02</month><year>2020</year></pub-date><volume>6</volume><issue>2</issue><fpage>189</fpage><lpage>196</lpage><history><date date-type="received"><day>19</day><month>10</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 American Chemical Society</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="oc9b01071_0006" id="ab-tgr1"/></p><p>Influenza virus circulates
in human, avian, and swine hosts, causing seasonal epidemic and occasional
pandemic outbreaks. Influenza neuraminidase, a viral surface glycoprotein,
has two sialic acid binding sites. The catalytic (primary) site, which
also binds inhibitors such
as oseltamivir carboxylate, is responsible for cleaving the sialic
acid linkages that bind viral progeny to the host cell. In contrast,
the functional annotation of the secondary site remains unclear. Here,
we better characterize these two sites through the development of
an all-atom, explicitly solvated, and experimentally based integrative
model of the pandemic influenza A H1N1 2009 viral envelope, containing
&#x0223c;160 million atoms and spanning &#x0223c;115 nm in diameter.
Molecular dynamics simulations of this crowded subcellular environment,
coupled with Markov state model theory, provide a novel framework
for studying realistic molecular systems at the mesoscale and allow
us to quantify the kinetics of the neuraminidase 150-loop transition
between the open and closed states. An analysis of chloride ion occupancy
along the neuraminidase surface implies a potential new role for the
neuraminidase secondary site, wherein the terminal sialic acid residues
of the linkages may bind before transfer to the primary site where
enzymatic cleavage occurs. Altogether, our work breaks new ground
for molecular simulation in terms of size, complexity, and methodological
analyses of the components. It also provides fundamental insights
into the understanding of substrate recognition processes for this
vital influenza drug target, suggesting a new strategy for the development
of anti-influenza therapeutics.</p></abstract><abstract abstract-type="short"><p>Molecular dynamics
simulations and chloride ion analyses provide fundamental insights
into the understanding of substrate recognition processes for two
sialic binding sites of influenza neuraminidase.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>oc9b01071</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>oc9b01071</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Influenza
virus infection is responsible for millions of deaths worldwide each
year. The Center for Disease Control estimates that pandemic influenza
A H1N1 2009 (pH1N1) affected 60.8 million people, resulting in 12468
casualties in the United States alone.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> Along with
others, this strain dramatically contributes to yearly epidemics,
continuously fueling concerns about the emergence of a new pandemic
strain. In addition, the increasingly widespread resistance to antiviral
medications is compounding this threat,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> thus requiring the development of novel approaches for the prevention
and treatment of influenza virus infection. One such strategy is to
target the viral surface glycoprotein neuraminidase (NA), which promotes
viral progeny release from the host cell by cleaving terminal sialic
acid residues.<sup><xref ref-type="bibr" rid="ref4">4</xref>&#x02212;<xref ref-type="bibr" rid="ref6">6</xref></sup> Previous work has identified the importance of characterizing
the dynamics of the NA catalytic site for drug design,<sup><xref ref-type="bibr" rid="ref7">7</xref>&#x02212;<xref ref-type="bibr" rid="ref12">12</xref></sup> understanding mechanisms of antiviral resistance,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> and deciphering the mechanisms underlying substrate binding.<sup><xref ref-type="bibr" rid="ref14">14</xref>&#x02212;<xref ref-type="bibr" rid="ref18">18</xref></sup></p><p>The catalytic (primary, 1&#x000b0;) site of NA is highly flexible,
in part due to the adjacent 150- and 430-loops (residues 147&#x02013;152
and 429&#x02013;433, respectively, N2 numbering).<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> The significance of this flexibility is
highlighted by the structural comparison of the phylogenetically distinct
group-1 (N1, N4, N5, and N8) and group-2 (N2, N3, N6, N7, and N9)
NAs, which illustrates that the opening of the 150-loop in the group-1
structures leads to the formation of the so-called 150-cavity<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> that can bind compounds with increased specificity
and potency.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> However, crystal structures
of pH1N1 NA (pN1) reveal that, unlike all other group-1 NAs, its 150-loop
is closed, and therefore no 150-cavity is present.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> In contrast, previous investigations utilizing molecular
dynamics (MD) simulations have found that the 150-loop of pN1 is in
the open state &#x0223c;60&#x02013;65% of the time.<sup><xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup></p><p>NA also contains a secondary (2&#x000b0;)
sialic acid binding site adjacent to the catalytic site. This site
was first identified as a hemadsorption site in avian-origin influenza
NAs<sup><xref ref-type="bibr" rid="ref22">22</xref>&#x02212;<xref ref-type="bibr" rid="ref26">26</xref></sup> and was not initially believed to be present in swine-origin strains
due to nonconservation of critical residues at this site.<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref27">27</xref></sup> However, more recent studies provide support for the presence of
a 2&#x000b0; site in swine-origin influenza NAs, including pN1.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref></sup> The precise mechanism by which this 2&#x000b0; site functions remains
unclear; however, a number of studies have demonstrated its role in
receptor binding<sup><xref ref-type="bibr" rid="ref28">28</xref>&#x02212;<xref ref-type="bibr" rid="ref32">32</xref></sup> and catalytic efficiency.<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref></sup> In addition, previous
Brownian dynamics (BD) simulations of single glycoproteins and various
ligands suggested that both endogenous substrates and the drug oseltamivir
carboxylate bind faster to the 2&#x000b0; site than the 1&#x000b0; site
(i.e., the <italic>k</italic><sub>on</sub> rate is 2- and 7-fold higher
for the N1 and N2 2&#x000b0; site, respectively, vs the corresponding
1&#x000b0; site).<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Finally, the 2&#x000b0; site
has recently been identified as a target for a novel influenza virus
inhibitor,<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup> further highlighting the need
to understand its role in viral infectivity.</p><p>To study the 1&#x000b0;
and 2&#x000b0; sites in the context of the viral surface, we used integrative
modeling to construct a fully atomistic model of the pH1N1 viral envelope
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Figure S1</ext-link> of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Supporting Information</ext-link> (SI)). The model was built using high-resolution
crystallographic structures of individual glycoproteins (&#x0223c;1.9&#x02013;2.6
&#x000c5; resolution)<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref35">35</xref></sup> that were spatially positioned
according to a lower-resolution cryo-electron tomography (cryo-ET,
&#x0223c;16&#x02013;20 &#x000c5; resolution) map of a viral particle.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Our viral envelope construct includes 30 NA
tetramers (120 monomers) and 236 hemagglutinin (HA) trimers (708 monomers)
embedded in a phospholipid bilayer, with realistic density and patterning
taken from the cryo-ET. The entire pH1N1 all-atom system modeled here
amounts to &#x0223c;160 million atoms (fully solvated) and is &#x0223c;115
nm in diameter. As such, it is among the largest biophysical systems
yet studied with all-atom molecular dynamics.<sup><xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref38">38</xref></sup> A complete description of the integrative modeling and computational
approaches used to build the viral envelope is provided in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">SI</ext-link> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">section S1.3</ext-link>).
Additional details can also be found in Amaro et al.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup></p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Mesoscale simulations enhance conformational sampling of the viral
glycoproteins. (A) A fully intact all-atom model of the influenza
A H1N1 2009 (pH1N1) viral envelope, containing over 160 million atoms,
shown without explicit water molecules, was simulated with all-atom
MD simulations. Hemagglutinin (HA) glycoproteins shown in royal (dark)
blue, neuraminidase (NA) glycoproteins shown in ice (light) blue.
(B) Top view of a single NA monomer in surface representation with
the catalytic site (white), secondary site (yellow), 150-loop (green),
and 430-loop (red) highlighted. (C&#x02013;E) Principal component analysis
(PCA) was performed by considering the motions of the C<sub>&#x003b1;</sub> atoms of 19 1&#x000b0; pocket residues. PCA histograms were independently
normalized so the bins containing the minimum and maximum number of
points were blue and red, respectively. (C) PCA of the four monomers
sampled during a single-NA-tetramer simulation (&#x0201c;single-glycoprotein&#x0201d;).
(D) PCA of the 120 monomeric trajectories extracted during the last
8.33 ns of the viral envelope simulation (&#x0201c;terminal-envelope&#x0201d;).
(E) PCA of all 120 monomeric trajectories extracted from the full
simulation of the viral envelope (&#x0201c;complete-envelope&#x0201d;).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="oc9b01071_0001" id="gr1" position="float"/></fig><p>Over the past decade, studies of viruses at the
molecular and coarse-grained (CG) levels have given unique insights
into these systems, complementing and extending available experimental
data by providing highly detailed models at never-before-seen scales
as well as suggesting testable biological hypotheses (predictions).<sup><xref ref-type="bibr" rid="ref40">40</xref>,<xref ref-type="bibr" rid="ref41">41</xref></sup> Work by Schulten and co-workers established the first explicitly
solvated atomic MD simulation of an intact virus, the satellite tobacco
mosaic virus (&#x0223c;17 nm diameter, &#x0223c;1 million atoms, 50
ns dynamics), in 2006.<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> Zink and Grubmuller
in 2009 used steered MD to explore the dynamics of the explicitly
solvated icosahedral shell of the southern bean mosaic virus (&#x0223c;36
nm diameter, &#x0223c;4.5 million atoms, 100 ns).<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> In 2010, Ayton and Voth developed and simulated an implicitly
solvated CG representation of the immature HIV-1 virion (&#x0223c;125
nm diameter, 280,000 CG particles).<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> In
2012, Larsson and co-workers simulated with explicitly solvated all-atom
MD the satellite tobacco necrosis virus (&#x0223c;17 nm diameter, &#x0223c;1.2
million atoms, &#x0223c;1 us),<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> and Roberts
et al. developed a fully atomic poliovirus (&#x0223c;30 nm diameter,
&#x0223c;2.8&#x02013;4 million atoms, 50 ns).<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> In 2013, Schulten and co-workers built and simulated a fully atomic
representation of the HIV capsid (&#x0223c;70 nm diameter, &#x0223c;64
million atoms, &#x0223c;100 ns),<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> and Andoh
et al. in 2014 simulated an all-atom poliovirus capsid (&#x0223c;30
nm diameter, &#x0223c;6.5 million atoms, &#x0223c;200 ns).<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> Sansom and colleagues in 2015 reported an explicitly
solvated CG influenza virus simulation (&#x0223c;80 nm diameter, 5
million particles).<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> In two separate studies
in 2016, Reddy and Sansom<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> and Bond, Verma,
and co-workers,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> reported CG simulations
of the Dengue viral membrane (&#x0223c;50 nm diameter, &#x0223c;1 million
particles). In addition to the rich structural, dynamical, and biophysical
insights that these studies each provided, the investigations have
collectively pushed the capabilities of molecular simulation, often
relying on the world&#x02019;s fastest and most advanced computing
architectures.</p><p>As the first explicitly solvated atomic-scale
simulation of a viral lipid envelope (&#x0223c;115 nm diameter, &#x0223c;160
million particles, &#x0223c;121 ns), the work reported here breaks
new ground in molecular simulation. To further characterize the structural
dynamics of the viral envelope and its glycoproteins, we combined
our mesoscale all-atom MD simulations with Markov state model (MSM)
theory,<sup><xref ref-type="bibr" rid="ref51">51</xref>&#x02212;<xref ref-type="bibr" rid="ref53">53</xref></sup> thus enabling the extraction of long-time-scale (e.g.,
microseconds) individual glycoprotein dynamics in a crowded environment
from the short-time-scale MD (e.g., nanoseconds) of the fully intact
viral surface. The accuracy and utility of MSMs have been demonstrated
by experimental validation for many use cases, including protein&#x02013;protein
binding, small-molecule binding kinetics, and protein-folding rate
prediction.<sup><xref ref-type="bibr" rid="ref54">54</xref>&#x02212;<xref ref-type="bibr" rid="ref56">56</xref></sup> Correspondingly, the approach reported here, which
relies on the many copies of single glycoproteins present within a
biologically accurate environment, provides a novel methodological
advancement for extracting long-time-scale dynamics from short simulations
through the powerful MSM theoretical framework at subcellular and
cellular scales.</p><p>Here, we quantitatively compare how calculated
protein dynamics differ when simulating many proteins in a single
subcellular environment versus simulating single proteins in isolation.
By exploiting the whole pH1N1 viral envelope treated entirely with
atomic resolution, this study provides unique insights into the two
sialic acid binding sites of NA (e.g., 1&#x000b0; and 2&#x000b0;). Our mesoscale
atomic simulations suggest that the NA 1&#x000b0; site is even more flexible
than previously appreciated and provide the first rigorous kinetic
characterization of the 150-loop dynamics. Furthermore, our work suggests
that the 2&#x000b0; site, which is more solvent exposed and, in some
strains, has a higher <italic>k</italic><sub>on</sub> rate than the
1&#x000b0; site,<sup><xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref39">39</xref></sup> may be responsible for initially
capturing sialic acid residues, which are then electrostatically guided
to the 1&#x000b0; site for enzymatic cleavage. Within this context, our
mesoscale simulations unveil an unprecedented cooperative interplay
between the two sites that further illuminates the process of sialic
acid/oseltamivir carboxylate recognition and 2&#x000b0; site functional
annotation. This fundamental discovery may be used as a rationale
for the development of novel anti-influenza small-molecule therapeutics
targeting NA.</p></sec><sec id="sec2"><title>Influenza Virus All-Atom Simulations</title><p>All-atom MD simulations of the pH1N1 viral envelope were performed
using NAMD2.10<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> and CHARMM36 all-atom
additive force fields.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> The system was
fully solvated with explicit water molecules (TIP3P force field<sup><xref ref-type="bibr" rid="ref59">59</xref></sup>), while ions were described using Beglov and
Roux force fields.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> To broaden conformational
sampling and more efficiently use supercomputer resources, the initial
simulation was forked twice, generating two additional shorter daughter
simulations (schematic representation in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Figure S2</ext-link>). Taken together, these simulations achieved a comprehensive
simulation time of &#x0223c;121 ns. The complete viral envelope simulation
included 30 NA tetramers, yielding 14.5 &#x003bc;s of monomeric simulation
(121 ns &#x000d7; 30 tetramers &#x000d7; 4 monomers/tetramer), and 236 HA
tetramers, accounting for 85.6 &#x003bc;s of monomeric dynamics (121
ns &#x000d7; 236 tetramers &#x000d7; 3 monomers/trimer). Each glycoprotein
structure used to build the initial viral envelope system was taken
from fully equilibrated single-glycoprotein MD simulations (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">sections S1.1&#x02013;S1.2</ext-link> for computational details
relative to these sets of simulations). The viral envelope simulations
were run on the Blue Waters petascale supercomputer using 114688 processors,
equivalent to 16384 Blue Waters nodes or 4096 physical nodes. The
simulation averaged 25.57 steps/sec. Frames were written every 10,000
steps (20 ps), ultimately occupying 11.66 terabytes of disk space.
Data analysis drew upon conformations extracted at equally spaced
time points from these trajectories. The adopted MD protocol for the
viral envelope simulations is fully described in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">section S1.4</ext-link>, including the NAMD input file. The physical
properties of the virus (RMSD, RMSF analyses) and its lipid bilayer
(curvature, motions) per the simulations are reported in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">sections S1.5&#x02013;S1.6</ext-link> and shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Figures S3&#x02013;S9</ext-link>).</p><p>To explore the flexibility
of the 1&#x000b0; pocket (shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Figure S10</ext-link>), we concatenated the MD trajectories of all 120 NA monomers and
performed principal component analysis (PCA) of 19 catalytic-pocket-lining
NA residues by considering their C<sub>&#x003b1;</sub> atoms (heatmap, <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C&#x02013;E). We selected
these 19 residues because they are homologous to those within 5 &#x000c5;
of the crystallographic oseltamivir carboxylate from the 2HU4 structure.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> PCA details, including indices of the catalytic
and active site residues used in the analysis, are provided in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">section S1.7</ext-link>.</p><p>To judge whether mesoscale
simulations enhance conformational sampling, we compared the viral
envelope full simulation (referred to as &#x0201c;complete-envelope&#x0201d;, <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>E) to five long time
scale simulations of isolated NA tetramers embedded in small lipid-bilayer
patches, described in a previous work (&#x0201c;single-glycoprotein&#x0201d;, <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C).<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> A fair comparison requires that the sampling of the two
systems be consistent in terms of the actual simulation length. The
viral envelope full simulation sampled 14.5 &#x003bc;s of monomeric
dynamics, but the five simulations of isolated NA tetramers sampled
only 1.0 &#x003bc;s of monomeric dynamics (5 simulations &#x000d7; 50 ns/simulation
&#x000d7; 1 NA tetramer &#x000d7; 4 monomers/tetramer). Thus, to improve
the comparison, we considered only the final 8.33 ns of the viral
envelope simulation, which is equivalent to 1.0 &#x003bc;s of monomeric
dynamics (1 simulation &#x000d7; 8.33 ns/simulation &#x000d7; 30 NA tetramers
&#x000d7; 4 monomers/tetramer) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D). We refer to this truncated segment of the full
simulation as the &#x0201c;terminal-envelope&#x0201d; simulation. In
all cases, the motions of the C<sub>&#x003b1;</sub> atoms of the same
19 residues were projected onto the first two principal components
of the viral envelope NA trajectories, and the resulting heatmaps
were compared (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C&#x02013;E). Strikingly, the PCA of the NA catalytic site residues
indicates that the viral envelope simulation more thoroughly explored
the conformational landscape, even after controlling for total simulation
time.</p><p>To better study the 1&#x000b0; site conformations sampled
by the viral envelope simulation, we applied <italic>k</italic>-means
clustering to the PCA points of <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>E. A visual inspection of cluster centroids corresponding
to four representative 1&#x000b0; site conformations (shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Figure S10</ext-link>) reveals that R292 and R371, two key
residues known to interact with the sialic acid carboxylate group,
are the most flexible. In contrast, the carboxylate-stabilizing R152
residue moves outward in only one of the four representative conformations.
Other pocket-lining residues such as R118 and D151, which previous
works suggest may play a role in the molecular mechanisms of oseltamivir
resistance,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> are also relatively flexible
in the apo state.</p><p>The PCA analysis demonstrates that the viral
envelope simulation more thoroughly sampled distinct 1&#x000b0; pocket
states (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>E)
that are scarcely populated in the single glycoprotein (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C). This holds true even when
comparing the terminal-envelope (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D) simulation to the single-glycoprotein
simulations (where the total sampling time is equal). The enhanced
conformational sampling may simply be a product of the large number
of NA copies blanketed across the viral surface; however, we do expect
some effects from the viral surface environment, including long-range
electrostatic forces and glycoprotein&#x02013;glycoprotein interactions
that only the viral envelope simulation can capture.</p></sec><sec id="sec3"><title>pN1 Catalytic Site Structure and
Dynamics</title><p>To explore the dynamics of the catalytic site, we
analyzed the volumes of the 1&#x000b0; pocket and adjacent regions over
the course of the entire viral envelope simulation (120 NA monomers, <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>).<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> The volumes ranged from 450 to 4440 &#x000c5;<sup>3</sup>,
with an average of 1536 &#x000c5;<sup>3</sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Table S1</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">section S1.8</ext-link>). By comparison,
the starting crystal structure pN1 (PDB ID: 3NSS(<xref ref-type="bibr" rid="ref20">20</xref>)) with a closed 150-cavity has a volume of 800 &#x000c5;<sup>3</sup>, and the structure of a nonpandemic N1 (PDB ID: 2HTY(<xref ref-type="bibr" rid="ref12">12</xref>)) with an open 150-cavity has a volume of 1088 &#x000c5;<sup>3</sup>. This indicates that the volume and depth of the catalytic
pocket and adjacent regions can increase remarkably over what has
been observed in crystal structures (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>C). Contributing to this additional cavity
volume and depth are two novel subpockets near residues G351 and E227,
buried deep inside, but contiguous with, the 1&#x000b0; site (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B). An analysis with
FTMap, a server for mapping ligand binding hot spots in macromolecules,<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> suggests that the G351 subpocket can accommodate
small-molecule ligands. Similar to the 150-cavity and 430-cavity,
the G351- and E227-adjacent subpockets may provide new ligand-binding
opportunities.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Volumetric and ligand binding &#x0201c;hot spot&#x0201d;
analyses of the 1&#x000b0; catalytic site and adjacent regions. (A) NA
is shown in ice blue ribbon, and the pocket volume is filled with
semitransparent gel. The 1&#x000b0; active site, 430-loop, and 150-loop
are visible. (B) NA is shown as a solid gradient, and ligand-binding
hotspots are metallic. A portion of the surface-rendered protein was
removed to facilitate visualization of internal cavities. This NA
conformation has a notably open G351 pocket, which has a high propensity
to bind ligands. (C) A histogram of the NA catalytic-site volumes
sampled during the MD simulations. As reference, the volumes of the
same active-site cavity from two crystal structures are indicated
with black circled stars. The 3NSS(<xref ref-type="bibr" rid="ref20">20</xref>) structure
(pH1N1 with a closed 150-cavity) has a volume of 800 &#x000c5;<sup>3</sup>, and the 2HTY(<xref ref-type="bibr" rid="ref12">12</xref>) structure (H5N1 with an open 150-cavity)
has a pocket volume of 1088 &#x000c5;<sup>3</sup>. The simulated-pocket
volumes range from &#x0223c;450 to 4440 &#x000c5;<sup>3</sup> (intervals
3500&#x02013;4500 not shown), as reported in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Table S1</ext-link>; the average pocket volume is 1536 &#x000c5;<sup>3</sup>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="oc9b01071_0002" id="gr2" position="float"/></fig><p>The volumetric and dynamical properties of the
1&#x000b0; site revealed in our simulations suggest that NA can bind
many structurally distinct and complex sialoglycan receptors as part
of the host-cell recognition process. Indeed, human glycans are vastly
diverse in both their sugar composition and configuration (e.g., long,
short, biantennary, triantennary, etc.).<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> As such, the transient deepening and broadening of the 1&#x000b0; NA
site may allow the glycoprotein to accommodate bulkier (e.g., long,
bi/triantennary) and longer glycan receptors. Given that our simulations
model the entire viral envelope, it may be that full-pocket opening
only occurs in a crowded viral-surface environment. Alternatively,
our simulations may capture full-pocket opening because the viral
coat includes many replicates of individual glycoproteins, enabling
extensive conformational sampling.</p><p>Using the intramolecular
distance between the 150- and 430-loops as a metric for 150-cavity
formation, we constructed a two-state MSM from the conformations sampled
by the viral envelope simulation to estimate the time scales of 150-loop
opening and closing motions. Ultimately, we find the stationary distribution
(equilibrium probabilities) of the open and closed states to be similar
(0.53 and 0.47, respectively). Correspondingly, the time to transition
between the two states (i.e., the mean first-passage time (MFPT))
is also roughly equal (39 &#x000b1; 15 ns for open to closed and 29 &#x000b1;
11 ns from closed to open), indicating that loop opening and closing
occur at similar rates (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). MSM calculations are detailed in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">section S1.9</ext-link> and depicted in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Figures S11&#x02013;S14</ext-link>.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>A two-state MSM with representative structures from the viral envelope
simulation. The equilibrium populations of the open and closed states
are approximately equal in both the viral envelope and single-glycoprotein
simulations. Correspondingly, the mean first-passage times between
the states are approximately equal. The 150-loop and 430-loop are
represented as green and red ribbons, respectively.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="oc9b01071_0003" id="gr3" position="float"/></fig><p>To understand the impact of a crowded viral environment on
loop sampling, we used the same protocol to construct an MSM from
structures extracted from simulations of isolated NAs embedded in
planar bilayer patches.<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> The 150-loop
dynamics of both the viral envelope and single-glycoprotein simulations
are nearly equivalent; however, the error associated with the viral-envelope
MSM is much smaller, likely due to the increased simulation time.
The single-glycoprotein equilibrium probabilities of the open and
closed states were 0.61 and 0.39, respectively, and the MFPT ranges
(open to closed and closed to open after 50 &#x000b1; 96 ns and 72 &#x000b1;
44 ns, respectively) overlap with those calculated using the viral
envelope simulations. This comparison suggests that 150-cavity dynamics
are not influenced by the crowded environment of the viral envelope,
an expected result given that this pocket is oriented inward (toward
the neighboring three monomers of the same tetramer) rather than outward
(toward the environment).</p></sec><sec id="sec4"><title>Secondary Binding Site: Functional Annotation</title><p>We note that all FDA-approved NA inhibitors, as well as the endogenous
ligand sialic acid, contain negatively charged carboxylate groups.
Considering the hypothesis that the 2&#x000b0; site contributes to catalytic
efficiency by recruiting and keeping substrates within close proximity
to the catalytic site<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref></sup> and given that prior BD simulations
indicate that substrates bind faster to the 2&#x000b0; site than the
1&#x000b0; site,<sup><xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref39">39</xref></sup> we postulate that sialic acid
first binds to the more solvent-exposed 2&#x000b0; site. Subsequently,
the electrostatics of the NA surface guides the substrates to the
1&#x000b0; enzymatic site.</p><p>Although sialic acid substrates were
not included in the viral envelope simulation, we propose that the
negatively charged chloride anions in the bulk solvent surrounding
the NA monomers serve as a rough surrogate for negatively charged
ligand moieties that may associate with the glycoprotein surface.
To identify regions favorable to chloride occupancy, we concatenated
the 120 monomeric NA simulations and aligned them by the alpha carbons
of the 1&#x000b0; site. The chloride atoms were binned into 3375000 voxels
(0.67 &#x000c5; &#x000d7; 0.67 &#x000c5; &#x000d7; 0.67 &#x000c5; each). We focused
on voxels containing chloride counts greater than three standard deviations
above the mean. Notably, our simulations reveal that a volume of high
chloride occupancy connects the 1&#x000b0; and 2&#x000b0; sialic acid binding
sites (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A).
This path is wide enough to allow negatively charged small molecules
such as sialic acid or oseltamivir carboxylate to move from the 2&#x000b0;
site to the 1&#x000b0; catalytic site. Additional regions of high chloride
density are also depicted in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A.</p><p>To further explore the role of electrostatics
in the in this transfer mechanism, we calculated the electrostatic
potential of the 120 NA monomers at the end of MD simulations using
the adaptive Poisson&#x02013;Boltzmann solver (APBS 1.4) software.<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> When projected onto the NA surface, the electrostatic
potential ranging from &#x02212;1 <italic>k</italic><sub>b</sub><italic>T</italic>/e<sub><italic>c</italic></sub> to +1 <italic>k</italic><sub>b</sub><italic>T</italic>/<italic>e</italic><sub>c</sub> shows
a positive region connecting the two sites (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>B). Positively charged residues such as R118,
R368, R430, K432, and P431 (N2 numbering scheme) largely determine
this profile. Interestingly, the same analysis performed on the representative
NA structures with open and closed 150-loop pockets (extracted with
MSM and shown in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>) reveals that these residues are less exposed in the closed state
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Figure S15</ext-link>). These results provide evidence
that the two sites may act cooperatively, supporting the work of Lai
et al.,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> which confirmed that pN1 has
a 2&#x000b0; site that can bind sialic acid. It also supports the work
of Le et al.,<sup><xref ref-type="bibr" rid="ref66">66</xref></sup> which suggested electrostatic
funneling as being the main driving force for oseltamivir carboxylate
association to the active site. Chloride anion and electrostatic analyses
are detailed in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">section S1.10</ext-link>.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Chlorine anion
distribution within the NA binding sites. The chlorine anion distribution
(A) and the projection of the electrostatic potential onto the NA
surface (B) show the pathway between the 1&#x000b0; and 2&#x000b0; sites.
In panel A, NA is drawn as ice blue cartoon. Regions of high chloride
occupancy are illustrated as dotted silver bubbles. Two sialic acids
(PDB ID: 1MWE(<xref ref-type="bibr" rid="ref24">24</xref>)) are superimposed in the catalytic
(center) and 2&#x000b0; (upper right) sites for reference.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> In panel B the NA surface is colored with a
palette varying from red (negative) to royal blue (positive), representing
electrostatic potential values of &#x02212;1 <italic>k</italic><sub>b</sub><italic>T</italic>/<italic>e</italic><sub>c</sub> and +1 <italic>k</italic><sub>b</sub><italic>T</italic>/<italic>e</italic><sub>c</sub>, respectively. The path connecting the 2&#x000b0; site with the catalytic
site is shown as a dashed arrow between circles fading from yellow
(2&#x000b0; site) to white (catalytic site).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="oc9b01071_0004" id="gr4" position="float"/></fig><p>Taken together, these results suggest a biophysical mechanism for
the previously uncharacterized 2&#x000b0; site. Sialic acid receptors
may first bind the 2&#x000b0; site before being transferred to the 1&#x000b0;
sialidase site (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>). We propose that our chloride distribution analysis is well suited
for studying these possible mechanisms of molecular transfer. In contrast
to a simple electrostatic map, our simulation-based analysis accounts
for both electrostatic and steric factors, as well as for the conformational
dynamics sampled over all 14.5 &#x003bc;s of the monomeric simulation
in the context of the whole viral-envelope environment. In addition,
the proposed &#x0201c;bind and transfer&#x0201d; mechanism is in good
agreement with prior experimental results and proposed mechanisms.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup></p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>The predicted sialic acid &#x0201c;bind and transfer&#x0201d;
mechanism. Yellow stars represent a sialic-acid-containing glycan
receptor. Ice blue half circles represent NA. The 1&#x000b0; catalytic
site and 2&#x000b0; site are also labeled.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="oc9b01071_0005" id="gr5" position="float"/></fig></sec><sec id="sec5"><title>Conclusions</title><p>Our work suggests a novel NA binding mechanism wherein a sialic
acid-containing substrate (e.g., a glycan receptor) first binds the
2&#x000b0; site, as predicted by earlier BD simulations.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> After binding, the substrate is transferred to the catalytic
site via electrostatic interactions. Finally, the catalytic site cleaves
the terminal sialic acid substrate. In other words, a budding viral
particle might use the 2&#x000b0; site to first attract the sialic acid-tipped
receptors before these are cleaved within the catalytic site, ultimately
allowing viral escape from the infected host-cell surface. MSM and
volumetric analyses also further expand the functional annotation
of the 1&#x000b0; site and surrounding regions, disclosing exceptionally
deep and broad catalytic-pocket conformations. These findings can
be exploited to design novel multipronged inhibitors capable of reaching
the additional NA cavities unveiled in our multiscale simulations.</p><p>Taken together, this information provides fundamental insights
into our understanding of sialic acid/oseltamivir carboxylate recognition,
suggesting new strategies for the development of NA inhibitors. Our
work also provides a novel methodological advancement for extracting
long-time-scale dynamics from short-time-scale simulations by applying
the powerful MSM theoretical framework at subcellular and cellular
scales.</p></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>Supporting
Information available online. The Supporting Information is available
free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acscentsci.9b01071?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acscentsci.9b01071</ext-link>.<list id="silist" list-type="simple"><list-item><p>A NAMD input script used
for the production run and the Jupyter notebook used to create the
MSM are provided as <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Supporting Information</ext-link>. Additional analysis scripts are available upon request. In addition,
the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">Supporting Information</ext-link> includes the
following: supplementary materials and methods, information regarding
building single-glycoprotein HA and NA structural models, details
of the single-glycoprotein HA and NA MD simulations, information regarding
building the viral envelope model from a simplified cryoelectron-tomography
&#x0201c;point model&#x0201d;, complete viral envelope all-atom MD simulations,
RMSD and RMSF analyses of the viral envelope MD simulations, viral
envelope lipid and curvature analysis, NA catalytic-site PCA, volumetric
and FTMap analysis, MSMs, and chloride anion and electrostatic analyses
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b01071/suppl_file/oc9b01071_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="oc9b01071_si_001.pdf"><caption><p>oc9b01071_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes2"><title>Author Contributions</title><p><sup>&#x000a7;</sup> J.D.D., S.E.K., and L.C. contributed equally. R.E.A. designed and
oversaw the research project. J.D.D. built the structures and performed
the MD simulations. R.E.A., J.D.D., S.E.K., L.C., P.U.L., and A.D.
performed the simulation analyses. J.D.D, L.C., P.U.L., and A.D. created
the figures. R.E.A., J.D.D., S.E.K., L.C., P.U.L., and A.D. wrote
the paper.</p></notes><notes notes-type="COI-statement" id="NOTES-d7e778-autogenerated"><p>The authors declare the following competing financial interest(s):
R.E.A. is a cofounder and on the scientific advisory board of, and
has equity interest in, Actavalon, Inc.</p></notes><ack><title>Acknowledgments</title><p>This work was funded
in part by the Director&#x02019;s New Innovator Award Program NIH DP2
OD007237 and the National Biomedical Computation Resource (NBCR) through
NIH P41 GM103426 to R.E.A. Computing support on the NSF Blue Waters
Petascale Computer was provided through NSF OAC-1811685. We thank
the NSF for access to the TACC Stampede supercomputer through CHE060073N
to R.E.A. and the Center for Research Computing at the University
of Pittsburgh for a computing allocation to J.D.D.. The authors also
thank Dr. Robert Malmstrom for providing sample MSM-building scripts
and useful discussions. This work is dedicated to the memory of Klaus
Schulten.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="gov" id="cit1"><person-group><collab>Centers for Disease
Control and Prevention</collab></person-group>. <source>Summary of
the 2017&#x02013;2018 Influenza Season</source>; United States Centers
for Disease Control and Prevention: <year>2018</year>; Vol. <volume>11</volume>, pp. <fpage>7</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Wang</surname><given-names>X.</given-names></name>; et al. <article-title>Epidemiology of avian influenza A H7N9 virus in human
beings across five epidemics in mainland China, 2013&#x02013;17: an
epidemiological study of laboratory-confirmed case series</article-title>. <source>Lancet Infect. Dis.</source>
<year>2017</year>, <volume>17</volume>, <fpage>822</fpage>&#x02013;<lpage>832</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(17)30323-7</pub-id>.<pub-id pub-id-type="pmid">28583578</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>De Clercq</surname><given-names>E.</given-names></name>
<article-title>Antiviral agents active against influenza A viruses</article-title>. <source>Nat. Rev. Drug Discovery</source>
<year>2006</year>, <volume>5</volume>, <fpage>1015</fpage>&#x02013;<lpage>1025</lpage>. <pub-id pub-id-type="doi">10.1038/nrd2175</pub-id>.<pub-id pub-id-type="pmid">17139286</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Hamilton</surname><given-names>B. S.</given-names></name>; <name><surname>Whittaker</surname><given-names>G. R.</given-names></name>; <name><surname>Daniel</surname><given-names>S.</given-names></name>
<article-title>Influenza virus-mediated membrane fusion: determinants
of hemagglutinin fusogenic activity and experimental approaches for
assessing virus fusion</article-title>. <source>Viruses</source>
<year>2012</year>, <volume>4</volume>, <fpage>1144</fpage>&#x02013;<lpage>1168</lpage>. <pub-id pub-id-type="doi">10.3390/v4071144</pub-id>.<pub-id pub-id-type="pmid">22852045</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>von Itzstein</surname><given-names>M.</given-names></name>
<article-title>The war against influenza: discovery
and development of sialidase inhibitors</article-title>. <source>Nat.
Rev. Drug Discovery</source>
<year>2007</year>, <volume>6</volume>, <fpage>967</fpage>&#x02013;<lpage>974</lpage>. <pub-id pub-id-type="doi">10.1038/nrd2400</pub-id>.<pub-id pub-id-type="pmid">18049471</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Gamblin</surname><given-names>S. J.</given-names></name>; <name><surname>Skehel</surname><given-names>J. J.</given-names></name>
<article-title>Influenza hemagglutinin and neuraminidase membrane
glycoproteins</article-title>. <source>J. Biol. Chem.</source>
<year>2010</year>, <volume>285</volume>, <fpage>28403</fpage>&#x02013;<lpage>28409</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R110.129809</pub-id>.<pub-id pub-id-type="pmid">20538598</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>An</surname><given-names>J.</given-names></name>; et al. <article-title>A novel small-molecule
inhibitor of the avian influenza H5N1 virus determined through computational
screening against the neuraminidase</article-title>. <source>J. Med.
Chem.</source>
<year>2009</year>, <volume>52</volume>, <fpage>2667</fpage>&#x02013;<lpage>2672</lpage>. <pub-id pub-id-type="doi">10.1021/jm800455g</pub-id>.<pub-id pub-id-type="pmid">19419201</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Feng</surname><given-names>E.</given-names></name>; et al. <article-title>Structure-based design
and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase
inhibitors</article-title>. <source>J. Med. Chem.</source>
<year>2013</year>, <volume>56</volume>, <fpage>671</fpage>&#x02013;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1021/jm3009713</pub-id>.<pub-id pub-id-type="pmid">23330908</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Wen</surname><given-names>W. H.</given-names></name>; et al. <article-title>Analogs of zanamivir
with modified C4-substituents as the inhibitors against the group-1
neuraminidases of influenza viruses</article-title>. <source>Bioorg.
Med. Chem.</source>
<year>2010</year>, <volume>18</volume>, <fpage>4074</fpage>&#x02013;<lpage>4084</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2010.04.010</pub-id>.<pub-id pub-id-type="pmid">20452227</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Rudrawar</surname><given-names>S.</given-names></name>; <name><surname>Dyason</surname><given-names>J. C.</given-names></name>; <name><surname>Rameix-Welti</surname><given-names>M.-A.</given-names></name>; <name><surname>Rose</surname><given-names>F. J.</given-names></name>; <name><surname>Kerry</surname><given-names>P. S.</given-names></name>; <name><surname>Russell</surname><given-names>R. J. M.</given-names></name>; <name><surname>van der Werf</surname><given-names>S.</given-names></name>; <name><surname>Thomson</surname><given-names>R. J.</given-names></name>; <name><surname>Naffakh</surname><given-names>N.</given-names></name>; <name><surname>von Itzstein</surname><given-names>M.</given-names></name>
<article-title>Novel sialic acid derivatives lock open the 150-loop
of an influenza A virus group-1 sialidase</article-title>. <source>Nat.
Commun.</source>
<year>2010</year>, <volume>1</volume>, <fpage>113</fpage><pub-id pub-id-type="doi">10.1038/ncomms1114</pub-id>.<pub-id pub-id-type="pmid">21081911</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Amaro</surname><given-names>R. E.</given-names></name>; et al. <article-title>Remarkable Loop Flexibility
in Avian Influenza N1 and Its Implications for Antiviral Drug Design</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2007</year>, <volume>129</volume>, <fpage>7764</fpage>&#x02013;<lpage>7765</lpage>. <pub-id pub-id-type="doi">10.1021/ja0723535</pub-id>.<pub-id pub-id-type="pmid">17539643</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Russell</surname><given-names>R. J.</given-names></name>; et al. <article-title>The structure of H5N1 avian influenza neuraminidase suggests new
opportunities for drug design</article-title>. <source>Nature</source>
<year>2006</year>, <volume>443</volume>, <fpage>45</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1038/nature05114</pub-id>.<pub-id pub-id-type="pmid">16915235</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Woods</surname><given-names>C. J.</given-names></name>; et al. <article-title>Long time scale GPU
dynamics reveal the mechanism of drug resistance of the dual mutant
I223R/H275Y neuraminidase from H1N1&#x02013;2009 influenza virus</article-title>. <source>Biochemistry</source>
<year>2012</year>, <volume>51</volume>, <fpage>4364</fpage>&#x02013;<lpage>4375</lpage>. <pub-id pub-id-type="doi">10.1021/bi300561n</pub-id>.<pub-id pub-id-type="pmid">22574858</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Amaro</surname><given-names>R. E.</given-names></name>; <name><surname>Cheng</surname><given-names>X.</given-names></name>; <name><surname>Ivanov</surname><given-names>I.</given-names></name>; <name><surname>Xu</surname><given-names>D.</given-names></name>; <name><surname>McCammon</surname><given-names>J. A. A.</given-names></name>
<article-title>Characterizing
Loop Dynamics and Ligand Recognition in Human- and Avian-Type Influenza
Neuraminidases via Generalized Born Molecular Dynamics and End-Point
Free Energy Calculations</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2009</year>, <volume>131</volume>, <fpage>4702</fpage>&#x02013;<lpage>4709</lpage>. <pub-id pub-id-type="doi">10.1021/ja8085643</pub-id>.<pub-id pub-id-type="pmid">19296611</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Hausmann</surname><given-names>J.</given-names></name>; <name><surname>Kretzschmar</surname><given-names>E.</given-names></name>; <name><surname>Garten</surname><given-names>W.</given-names></name>; <name><surname>Klenk</surname><given-names>H.-D.</given-names></name>
<article-title>N1 neuraminidase of influenza virus
A/FPV/Rostock/34 has haemadsorbing activity</article-title>. <source>J. Gen. Virol.</source>
<year>1995</year>, <volume>76</volume>, <fpage>1719</fpage>&#x02013;<lpage>1728</lpage>. <pub-id pub-id-type="doi">10.1099/0022-1317-76-7-1719</pub-id>.<pub-id pub-id-type="pmid">9049377</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Lai</surname><given-names>J. C. C.</given-names></name>; et al. <article-title>A secondary sialic acid binding site on influenza
virus neuraminidase: Fact or fiction?</article-title>. <source>Angew.
Chem., Int. Ed.</source>
<year>2012</year>, <volume>51</volume>, <fpage>2221</fpage>&#x02013;<lpage>2224</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201108245</pub-id>.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Sung</surname><given-names>J. C.</given-names></name>; <name><surname>Wynsberghe</surname><given-names>A. W. V.</given-names></name>; <name><surname>Amaro</surname><given-names>R. E.</given-names></name>; <name><surname>Li</surname><given-names>W. W.</given-names></name>; <name><surname>McCammon</surname><given-names>J. A.</given-names></name>
<article-title>Role of
Secondary Sialic Acid Binding Sites in Influenza N1 Neuraminidase</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2010</year>, <volume>132</volume>, <fpage>2883</fpage>&#x02013;<lpage>2885</lpage>. <pub-id pub-id-type="doi">10.1021/ja9073672</pub-id>.<pub-id pub-id-type="pmid">20155919</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Wang</surname><given-names>T.</given-names></name>; <name><surname>Wade</surname><given-names>R. C.</given-names></name>
<article-title>Comparative Binding Energy (COMBINE) Analysis of Influenza
Neuraminidase-Inhibitor Complexes</article-title>. <source>J. Med. Chem.</source>
<year>2001</year>, <volume>44</volume>, <fpage>961</fpage>&#x02013;<lpage>971</lpage>. <pub-id pub-id-type="doi">10.1021/jm001070j</pub-id>.<pub-id pub-id-type="pmid">11300878</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Amaro</surname><given-names>R. E.</given-names></name>; <name><surname>Swift</surname><given-names>R. V.</given-names></name>; <name><surname>Votapka</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>W. W.</given-names></name>; <name><surname>Walker</surname><given-names>R. C.</given-names></name>; <name><surname>Bush</surname><given-names>R. M.</given-names></name>
<article-title>Mechanism of 150-cavity
formation in influenza neuraminidase</article-title>. <source>Nat. Commun.</source>
<year>2011</year>, <volume>2</volume>, <fpage>388</fpage><pub-id pub-id-type="doi">10.1038/ncomms1390</pub-id>.<pub-id pub-id-type="pmid">21750542</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Li</surname><given-names>Q.</given-names></name>; et al. <article-title>The 2009 pandemic H1N1
neuraminidase N1 lacks the 150-cavity in its active site</article-title>. <source>Nat. Struct. Mol. Biol.</source>
<year>2010</year>, <volume>17</volume>, <fpage>1266</fpage>&#x02013;<lpage>1268</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.1909</pub-id>.<pub-id pub-id-type="pmid">20852645</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Han</surname><given-names>N.</given-names></name>; <name><surname>Mu</surname><given-names>Y.</given-names></name>
<article-title>Plasticity of 150-Loop in Influenza Neuraminidase Explored by Hamiltonian
Replica Exchange Molecular Dynamics Simulations</article-title>. <source>PLoS One</source>
<year>2013</year>, <volume>8</volume>, <elocation-id>e60995</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0060995</pub-id>.<pub-id pub-id-type="pmid">23593372</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Laver</surname><given-names>W. G.</given-names></name>; <name><surname>Colman</surname><given-names>P. M.</given-names></name>; <name><surname>Webster</surname><given-names>R. G.</given-names></name>; <name><surname>Hinshaw</surname><given-names>V. S.</given-names></name>; <name><surname>Air</surname><given-names>G. M.</given-names></name>
<article-title>Influenza
virus neuraminidase with hemagglutinin activity</article-title>. <source>Virology</source>
<year>1984</year>, <volume>137</volume>, <fpage>314</fpage>&#x02013;<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1016/0042-6822(84)90223-X</pub-id>.<pub-id pub-id-type="pmid">6485252</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Webster</surname><given-names>R. G.</given-names></name>; et al. <article-title>Antigenic structure and variation in an influenza virus N9 neuraminidase</article-title>. <source>J. Virol.</source>
<year>1987</year>, <volume>61</volume>, <fpage>2910</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.61.9.2910-2916.1987</pub-id>.<pub-id pub-id-type="pmid">3612957</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Varghese</surname><given-names>J. N.</given-names></name>; et al. <article-title>Structural evidence
for a second sialic acid binding site in avian influenza virus neuraminidases</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>1997</year>, <volume>94</volume>, <fpage>11808</fpage>&#x02013;<lpage>11812</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.22.11808</pub-id>.<pub-id pub-id-type="pmid">9342319</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Air</surname><given-names>G. M.</given-names></name>
<article-title>Influenza neuraminidase</article-title>. <source>Influenza Other Respir. Viruses</source>
<year>2012</year>, <volume>6</volume>, <fpage>245</fpage>&#x02013;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-2659.2011.00304.x</pub-id>.<pub-id pub-id-type="pmid">22085243</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Streltsov</surname><given-names>V. A.</given-names></name>; <name><surname>Pilling</surname><given-names>P.</given-names></name>; <name><surname>Barrett</surname><given-names>S.</given-names></name>; <name><surname>McKimm-Breschkin</surname><given-names>J. L.</given-names></name>
<article-title>Catalytic mechanism and novel receptor binding sites
of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3
HN)</article-title>. <source>Antiviral Res.</source>
<year>2015</year>, <volume>123</volume>, <fpage>216</fpage>&#x02013;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.08.014</pub-id>.<pub-id pub-id-type="pmid">26364554</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Kobasa</surname><given-names>D.</given-names></name>; <name><surname>Rodgers</surname><given-names>M. E.</given-names></name>; <name><surname>Wells</surname><given-names>K.</given-names></name>; <name><surname>Kawaoka</surname><given-names>Y.</given-names></name>
<article-title>Neuraminidase hemadsorption activity, conserved in
avian influenza A viruses, does not influence viral replication in
ducks</article-title>. <source>J. Virol.</source>
<year>1997</year>, <volume>71</volume>, <fpage>6706</fpage>&#x02013;<lpage>6713</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.71.9.6706-6713.1997</pub-id>.<pub-id pub-id-type="pmid">9261394</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Uhlendorff</surname><given-names>J.</given-names></name>; <name><surname>Matrosovich</surname><given-names>T.</given-names></name>; <name><surname>Klenk</surname><given-names>H.-D.</given-names></name>; <name><surname>Matrosovich</surname><given-names>M.</given-names></name>
<article-title>Functional significance of the hemadsorption
activity of influenza virus neuraminidase and its alteration in pandemic
viruses</article-title>. <source>Arch. Virol.</source>
<year>2009</year>, <volume>154</volume>, <fpage>945</fpage>&#x02013;<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1007/s00705-009-0393-x</pub-id>.<pub-id pub-id-type="pmid">19458903</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Dai</surname><given-names>M.</given-names></name>; <name><surname>McBride</surname><given-names>R.</given-names></name>; <name><surname>Dortmans</surname><given-names>J. C. F. M.</given-names></name>; <name><surname>Peng</surname><given-names>W.</given-names></name>; <name><surname>Bakkers</surname><given-names>M. J. G.</given-names></name>; <name><surname>de Groot</surname><given-names>R. J.</given-names></name>; <name><surname>van Kuppeveld</surname><given-names>F. J. M.</given-names></name>; <name><surname>Paulson</surname><given-names>J. C.</given-names></name>; <name><surname>de Vries</surname><given-names>E.</given-names></name>; <name><surname>de Haan</surname><given-names>C. A. M.</given-names></name>
<article-title>Mutation of the
Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase
Activity, Preceded the Emergence of H7N9 Influenza A Virus</article-title>. <source>J. Virol.</source>
<year>2017</year>, <volume>91</volume>, <fpage>91</fpage><pub-id pub-id-type="doi">10.1128/JVI.00049-17</pub-id>.</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Du</surname><given-names>W.</given-names></name>; <name><surname>Dai</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Boons</surname><given-names>G. J.</given-names></name>; <name><surname>Peeters</surname><given-names>B.</given-names></name>; <name><surname>van Kuppeveld</surname><given-names>F. J. M.</given-names></name>; <name><surname>de Vries</surname><given-names>E.</given-names></name>; <name><surname>de Haan</surname><given-names>C. A. M.</given-names></name>
<article-title>Substrate Binding by the Second Sialic
Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes
to Enzymatic Activity</article-title>. <source>J. Virol.</source>
<year>2018</year>, <volume>92</volume>, <fpage>e01243</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01243-18</pub-id>.<pub-id pub-id-type="pmid">30089692</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Du</surname><given-names>W.</given-names></name>; et al. <article-title>The 2nd sialic acid-binding
site of influenza A virus neuraminidase is an important determinant
of the hemagglutinin-neuraminidase-receptor balance</article-title>. <source>PLoS Pathog.</source>
<year>2019</year>, <volume>15</volume>, <elocation-id>e1007860</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007860</pub-id>.<pub-id pub-id-type="pmid">31181126</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Zeller</surname><given-names>F.</given-names></name>; <name><surname>Luitz</surname><given-names>M. P.</given-names></name>; <name><surname>Bomblies</surname><given-names>R.</given-names></name>; <name><surname>Zacharias</surname><given-names>M.</given-names></name>
<article-title>Multiscale
Simulation of Receptor&#x02013;Drug Association Kinetics: Application
to Neuraminidase Inhibitors</article-title>. <source>J. Chem. Theory
Comput.</source>
<year>2017</year>, <volume>13</volume>, <fpage>5097</fpage>&#x02013;<lpage>5105</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.7b00631</pub-id>.<pub-id pub-id-type="pmid">28820938</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Ivinson</surname><given-names>K.</given-names></name>; <name><surname>Deliyannis</surname><given-names>G.</given-names></name>; <name><surname>McNabb</surname><given-names>L.</given-names></name>; <name><surname>Grollo</surname><given-names>L.</given-names></name>; <name><surname>Gilbertson</surname><given-names>B.</given-names></name>; <name><surname>Jackson</surname><given-names>D.</given-names></name>; <name><surname>Brown</surname><given-names>L. E.</given-names></name>
<article-title>Salivary Blockade Protects the Lower
Respiratory Tract of Mice from Lethal Influenza Virus Infection</article-title>. <source>J. Virol.</source>
<year>2017</year>, <volume>91</volume>, <fpage>e00624</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00624-17</pub-id>.<pub-id pub-id-type="pmid">28446669</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Gilbertson</surname><given-names>B.</given-names></name>; <name><surname>Ng</surname><given-names>W. C.</given-names></name>; <name><surname>Crawford</surname><given-names>S.</given-names></name>; <name><surname>McKimm-Breschkin</surname><given-names>J. L.</given-names></name>; <name><surname>Brown</surname><given-names>L. E.</given-names></name>
<article-title>Mouse Saliva Inhibits Transit of Influenza Virus to
the Lower Respiratory Tract by Efficiently Blocking Influenza Virus
Neuraminidase Activity</article-title>. <source>J. Virol.</source>
<year>2017</year>, <volume>91</volume>, <fpage>e00145</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00145-17</pub-id>.<pub-id pub-id-type="pmid">28446666</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Xu</surname><given-names>R.</given-names></name>; et al. <article-title>Structural Basis of
Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus</article-title>. <source>Science (Washington, DC, U. S.)</source>
<year>2010</year>, <volume>328</volume>, <fpage>357</fpage>&#x02013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1126/science.1186430</pub-id>.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Harris</surname><given-names>A.</given-names></name>; et al. <article-title>Influenza virus pleiomorphy
characterized by cryoelectron tomography</article-title>. <source>Proc.
Natl. Acad. Sci. U. S. A.</source>
<year>2006</year>, <volume>103</volume>, <fpage>19123</fpage>&#x02013;<lpage>19127</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0607614103</pub-id>.<pub-id pub-id-type="pmid">17146053</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Singharoy</surname><given-names>A.</given-names></name>; et al. <article-title>Atoms to Phenotypes: Molecular Design Principles of Cellular Energy
Metabolism</article-title>. <source>Cell</source>
<year>2019</year>, <volume>179</volume>, <fpage>1098</fpage>&#x02013;<lpage>1111</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2019.10.021</pub-id>.<pub-id pub-id-type="pmid">31730852</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Karplus</surname><given-names>M.</given-names></name>
<article-title>Development of Multiscale Models
for Complex Chemical Systems: From H+H 2 to Biomolecules (Nobel Lecture)</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2014</year>, <volume>53</volume>, <fpage>9992</fpage>&#x02013;<lpage>10005</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201403924</pub-id>.</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Amaro</surname><given-names>R. E.</given-names></name>; et al. <article-title>A Computational Assay that Explores the Hemagglutinin/Neuraminidase
Functional Balance Reveals the Neuraminidase Secondary Site as a Novel
Anti-Influenza Target</article-title>. <source>ACS Cent. Sci.</source>
<year>2018</year>, <volume>4</volume>, <fpage>1570</fpage>&#x02013;<lpage>1577</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.8b00666</pub-id>.<pub-id pub-id-type="pmid">30555910</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Hadden</surname><given-names>J. A.</given-names></name>; <name><surname>Perilla</surname><given-names>J. R.</given-names></name>
<article-title>All-atom virus simulations</article-title>. <source>Curr. Opin. Virol.</source>
<year>2018</year>, <volume>31</volume>, <fpage>82</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.coviro.2018.08.007</pub-id>.<pub-id pub-id-type="pmid">30181049</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Huber</surname><given-names>R. G.</given-names></name>; <name><surname>Marzinek</surname><given-names>J. K.</given-names></name>; <name><surname>Holdbrook</surname><given-names>D. A.</given-names></name>; <name><surname>Bond</surname><given-names>P. J.</given-names></name>
<article-title>Multiscale molecular dynamics simulation approaches
to the structure and dynamics of viruses</article-title>. <source>Prog.
Biophys. Mol. Biol.</source>
<year>2017</year>, <volume>128</volume>, <fpage>121</fpage>&#x02013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2016.09.010</pub-id>.<pub-id pub-id-type="pmid">27765545</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Freddolino</surname><given-names>P. L.</given-names></name>; <name><surname>Arkhipov</surname><given-names>A. S.</given-names></name>; <name><surname>Larson</surname><given-names>S. B.</given-names></name>; <name><surname>McPherson</surname><given-names>A.</given-names></name>; <name><surname>Schulten</surname><given-names>K.</given-names></name>
<article-title>Molecular dynamics simulations of
the complete satellite tobacco mosaic virus</article-title>. <source>Structure</source>
<year>2006</year>, <volume>14</volume>, <fpage>437</fpage>&#x02013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2005.11.014</pub-id>.<pub-id pub-id-type="pmid">16531228</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Zink</surname><given-names>M.</given-names></name>; <name><surname>Grubm&#x000fc;ller</surname><given-names>H.</given-names></name>
<article-title>Mechanical properties of the icosahedral shell of southern
bean mosaic virus: A molecular dynamics study</article-title>. <source>Biophys. J.</source>
<year>2009</year>, <volume>96</volume>, <fpage>1350</fpage>&#x02013;<lpage>1363</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2008.11.028</pub-id>.<pub-id pub-id-type="pmid">19217853</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Ayton</surname><given-names>G. S.</given-names></name>; <name><surname>Voth</surname><given-names>G. A.</given-names></name>
<article-title>Multiscale computer simulation of the immature HIV-1
virion</article-title>. <source>Biophys. J.</source>
<year>2010</year>, <volume>99</volume>, <fpage>2757</fpage>&#x02013;<lpage>2765</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2010.08.018</pub-id>.<pub-id pub-id-type="pmid">21044572</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Roberts</surname><given-names>J. A.</given-names></name>; <name><surname>Kuiper</surname><given-names>M. J.</given-names></name>; <name><surname>Thorley</surname><given-names>B. R.</given-names></name>; <name><surname>Smooker</surname><given-names>P. M.</given-names></name>; <name><surname>Hung</surname><given-names>A.</given-names></name>
<article-title>Investigation of a predicted N-terminal
amphipathic &#x003b1;-helix using atomistic molecular dynamics simulation
of a complete prototype poliovirus virion</article-title>. <source>J.
Mol. Graphics Modell.</source>
<year>2012</year>, <volume>38</volume>, <fpage>165</fpage>&#x02013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmgm.2012.06.009</pub-id>.</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Zhao</surname><given-names>G.</given-names></name>; et al. <article-title>Mature HIV-1 capsid structure by cryo-electron microscopy
and all-atom molecular dynamics</article-title>. <source>Nature</source>
<year>2013</year>, <volume>497</volume>, <fpage>643</fpage>&#x02013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1038/nature12162</pub-id>.<pub-id pub-id-type="pmid">23719463</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Andoh</surname><given-names>Y.</given-names></name>; et al. <article-title>All-atom molecular dynamics
calculation study of entire poliovirus empty capsids in solution</article-title>. <source>J. Chem. Phys.</source>
<year>2014</year>, <volume>141</volume>, <fpage>165101</fpage><pub-id pub-id-type="doi">10.1063/1.4897557</pub-id>.<pub-id pub-id-type="pmid">25362342</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Reddy</surname><given-names>T.</given-names></name>; et al. <article-title>Nothing to Sneeze At:
A Dynamic and Integrative Computational Model of an Influenza A Virion</article-title>. <source>Structure</source>
<year>2015</year>, <volume>23</volume>, <fpage>584</fpage>&#x02013;<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2014.12.019</pub-id>.<pub-id pub-id-type="pmid">25703376</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Reddy</surname><given-names>T.</given-names></name>; <name><surname>Sansom</surname><given-names>M. S. P.</given-names></name>
<article-title>The Role of the Membrane in the Structure
and Biophysical Robustness of the Dengue Virion Envelope</article-title>. <source>Structure</source>
<year>2016</year>, <volume>24</volume>, <fpage>375</fpage>&#x02013;<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2015.12.011</pub-id>.<pub-id pub-id-type="pmid">26833387</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Marzinek</surname><given-names>J. K.</given-names></name>; <name><surname>Holdbrook</surname><given-names>D. A.</given-names></name>; <name><surname>Huber</surname><given-names>R. G.</given-names></name>; <name><surname>Verma</surname><given-names>C.</given-names></name>; <name><surname>Bond</surname><given-names>P. J.</given-names></name>
<article-title>Pushing the Envelope: Dengue Viral Membrane Coaxed
into Shape by Molecular Simulations</article-title>. <source>Structure</source>
<year>2016</year>, <volume>24</volume>, <fpage>1410</fpage>&#x02013;<lpage>1420</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2016.05.014</pub-id>.<pub-id pub-id-type="pmid">27396828</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Pande</surname><given-names>V. S.</given-names></name>; <name><surname>Beauchamp</surname><given-names>K.</given-names></name>; <name><surname>Bowman</surname><given-names>G. R.</given-names></name>
<article-title>Everything you wanted to know about Markov State Models
but were afraid to ask</article-title>. <source>Methods</source>
<year>2010</year>, <volume>52</volume>, <fpage>99</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymeth.2010.06.002</pub-id>.<pub-id pub-id-type="pmid">20570730</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Prinz</surname><given-names>J. H.</given-names></name>; et al. <article-title>Markov models of molecular
kinetics: Generation and validation</article-title>. <source>J. Chem.
Phys.</source>
<year>2011</year>, <volume>134</volume>, <fpage>174105</fpage><pub-id pub-id-type="doi">10.1063/1.3565032</pub-id>.<pub-id pub-id-type="pmid">21548671</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Chodera</surname><given-names>J. D.</given-names></name>; <name><surname>No&#x000e9;</surname><given-names>F.</given-names></name>
<article-title>Markov state
models of biomolecular conformational dynamics</article-title>. <source>Curr. Opin. Struct. Biol.</source>
<year>2014</year>, <volume>25</volume>, <fpage>135</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2014.04.002</pub-id>.<pub-id pub-id-type="pmid">24836551</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Plattner</surname><given-names>N.</given-names></name>; <name><surname>No&#x000e9;</surname><given-names>F.</given-names></name>
<article-title>Protein conformational plasticity
and complex ligand-binding kinetics explored by atomistic simulations
and Markov models</article-title>. <source>Nat. Commun.</source>
<year>2015</year>, <volume>6</volume>, <fpage>7653</fpage><pub-id pub-id-type="doi">10.1038/ncomms8653</pub-id>.<pub-id pub-id-type="pmid">26134632</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Plattner</surname><given-names>N.</given-names></name>; <name><surname>Doerr</surname><given-names>S.</given-names></name>; <name><surname>De Fabritiis</surname><given-names>G.</given-names></name>; <name><surname>No&#x000e9;</surname><given-names>F.</given-names></name>
<article-title>Complete protein-protein association kinetics in atomic
detail revealed by molecular dynamics simulations and Markov modelling</article-title>. <source>Nat. Chem.</source>
<year>2017</year>, <volume>9</volume>, <fpage>1005</fpage>&#x02013;<lpage>1011</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.2785</pub-id>.<pub-id pub-id-type="pmid">28937668</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Voelz</surname><given-names>V. A.</given-names></name>; <name><surname>Bowman</surname><given-names>G. R.</given-names></name>; <name><surname>Beauchamp</surname><given-names>K.</given-names></name>; <name><surname>Pande</surname><given-names>V. S.</given-names></name>
<article-title>Molecular Simulation
of ab Initio Protein Folding for a Millisecond Folder NTL9(1&#x02013;39)</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2010</year>, <volume>132</volume>, <fpage>1526</fpage>&#x02013;<lpage>1528</lpage>. <pub-id pub-id-type="doi">10.1021/ja9090353</pub-id>.<pub-id pub-id-type="pmid">20070076</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Phillips</surname><given-names>J. C.</given-names></name>; et al. <article-title>Scalable molecular dynamics with NAMD</article-title>. <source>J. Comput.
Chem.</source>
<year>2005</year>, <volume>26</volume>, <fpage>1781</fpage>&#x02013;<lpage>1802</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20289</pub-id>.<pub-id pub-id-type="pmid">16222654</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Huang</surname><given-names>J.</given-names></name>; <name><surname>MacKerell</surname><given-names>A. D.</given-names></name>
<article-title>CHARMM36
all-atom additive protein force field: Validation based on comparison
to NMR data</article-title>. <source>J. Comput. Chem.</source>
<year>2013</year>, <volume>34</volume>, <fpage>2135</fpage>&#x02013;<lpage>2145</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.23354</pub-id>.<pub-id pub-id-type="pmid">23832629</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Jorgensen</surname><given-names>W. L.</given-names></name>; <name><surname>Chandrasekhar</surname><given-names>J.</given-names></name>; <name><surname>Madura</surname><given-names>J. D.</given-names></name>; <name><surname>Impey</surname><given-names>R. W.</given-names></name>; <name><surname>Klein</surname><given-names>M. L.</given-names></name>
<article-title>Comparison of simple
potential functions for simulating liquid water</article-title>. <source>J. Chem. Phys.</source>
<year>1983</year>, <volume>79</volume>, <fpage>926</fpage><pub-id pub-id-type="doi">10.1063/1.445869</pub-id>.</mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Beglov</surname><given-names>D.</given-names></name>; <name><surname>Roux</surname><given-names>B.</given-names></name>
<article-title>Finite representation
of an infinite bulk system: Solvent boundary potential for computer
simulations</article-title>. <source>J. Chem. Phys.</source>
<year>1994</year>, <volume>100</volume>, <fpage>9050</fpage>&#x02013;<lpage>9063</lpage>. <pub-id pub-id-type="doi">10.1063/1.466711</pub-id>.</mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Durrant</surname><given-names>J. D.</given-names></name>; <name><surname>Bush</surname><given-names>R. M.</given-names></name>; <name><surname>Amaro</surname><given-names>R. E.</given-names></name>
<article-title>Microsecond
Molecular Dynamics Simulations of Influenza Neuraminidase Suggest
a Mechanism for the Increased Virulence of Stalk-Deletion Mutants</article-title>. <source>J. Phys. Chem. B</source>
<year>2016</year>, <volume>120</volume>, <fpage>8590</fpage>&#x02013;<lpage>8599</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jpcb.6b02655</pub-id>.<pub-id pub-id-type="pmid">27141956</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Durrant</surname><given-names>J. D.</given-names></name>; <name><surname>Votapka</surname><given-names>L.</given-names></name>; <name><surname>S&#x000f8;rensen</surname><given-names>J.</given-names></name>; <name><surname>Amaro</surname><given-names>R. E.</given-names></name>
<article-title>POVME 2.0: An Enhanced Tool for Determining Pocket
Shape and Volume Characteristics</article-title>. <source>J. Chem. Theory
Comput.</source>
<year>2014</year>, <volume>10</volume>, <fpage>5047</fpage>&#x02013;<lpage>5056</lpage>. <pub-id pub-id-type="doi">10.1021/ct500381c</pub-id>.<pub-id pub-id-type="pmid">25400521</pub-id></mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Ngan</surname><given-names>C. H.</given-names></name>; et al. <article-title>FTMAP: extended protein
mapping with user-selected probe molecules</article-title>. <source>Nucleic Acids Res.</source>
<year>2012</year>, <volume>40</volume>, <fpage>W271</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks441</pub-id>.<pub-id pub-id-type="pmid">22589414</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Marino</surname><given-names>K.</given-names></name>; <name><surname>Bones</surname><given-names>J.</given-names></name>; <name><surname>Kattla</surname><given-names>J. J.</given-names></name>; <name><surname>Rudd</surname><given-names>P. M.</given-names></name>
<article-title>A systematic approach
to protein glycosylation analysis: a path through the maze</article-title>. <source>Nat. Chem. Biol.</source>
<year>2010</year>, <volume>6</volume>, <fpage>713</fpage>&#x02013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.437</pub-id>.<pub-id pub-id-type="pmid">20852609</pub-id></mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name><surname>Baker</surname><given-names>N. A.</given-names></name>; <name><surname>Sept</surname><given-names>D.</given-names></name>; <name><surname>Joseph</surname><given-names>S.</given-names></name>; <name><surname>Holst</surname><given-names>M. J.</given-names></name>; <name><surname>McCammon</surname><given-names>J. A.</given-names></name>
<article-title>Electrostatics
of nanosystems: application to microtubules and the ribosome</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2001</year>, <volume>98</volume>, <fpage>10037</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.181342398</pub-id>.<pub-id pub-id-type="pmid">11517324</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name><surname>Le</surname><given-names>L.</given-names></name>; <name><surname>Lee</surname><given-names>E. H.</given-names></name>; <name><surname>Hardy</surname><given-names>D. J.</given-names></name>; <name><surname>Truong</surname><given-names>T. N.</given-names></name>; <name><surname>Schulten</surname><given-names>K.</given-names></name>
<article-title>Molecular Dynamics Simulations Suggest
that Electrostatic Funnel Directs Binding of Tamiflu to Influenza
N1 Neuraminidases</article-title>. <source>PLoS Comput. Biol.</source>
<year>2010</year>, <volume>6</volume>, <elocation-id>e1000939</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1000939</pub-id>.<pub-id pub-id-type="pmid">20885781</pub-id></mixed-citation></ref></ref-list></back></article>